Target-controlled infusion
Showing 9976 - 10000 of >10,000
Diabetes, Type 2, Nutrition Poor, Food Deprivation Trial (Mid-Ohio Food Farmacy, Mid-Ohio Food Farmacy + Cooking for Diabetes,
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Mid-Ohio Food Farmacy
- +3 more
- (no location specified)
Aug 8, 2022
Diabetes, Pre Diabetes Trial in Orlando (Viome's Precision Nutrition Program (VPNP))
Recruiting
- Diabetes
- Pre Diabetes
- Viome's Precision Nutrition Program (VPNP)
-
Orlando, FloridaAdventHealth
Aug 2, 2022
Lung Cancer, Gastro-intestinal Cancer Trial in Toronto (GAM, exercise, health education)
Not yet recruiting
- Lung Cancer
- Gastro-intestinal Cancer
- GAM, exercise, health education
-
Toronto, Ontario, Canada
- +1 more
Aug 18, 2022
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)
Not yet recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- (no location specified)
Jun 15, 2022
Intracranial Arteriosclerosis, Stroke (CVA) or TIA Trial (Maurora® Sirolimus Eluting Stent System, APOLLO™ Intracranial Stent
Not yet recruiting
- Intracranial Arteriosclerosis
- Stroke (CVA) or TIA
- Maurora® Sirolimus Eluting Stent System
- APOLLO™ Intracranial Stent System
- (no location specified)
Jan 31, 2023
Chin Augmentation and Correction Trial in Canada (Hyaluronic Acid)
Completed
- Chin Augmentation and Correction
- Hyaluronic Acid
-
Calgary, Alberta, Canada
- +8 more
Jun 21, 2022
Preterm Labor Trial in Bani Suwayf (azithromycin)
Not yet recruiting
- Preterm Labor
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 25, 2023
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Healthy Volunteers Trial in Dijon (Provision of extended information on the conduct of complementary feeding, Provision of
Recruiting
- Healthy Volunteers
- Provision of extended information on the conduct of complementary feeding
- Provision of current official information on complementary feeding
-
Dijon, FranceCentre des Sciences du Goût et de l'Alimentation
Oct 21, 2022
Diabetes, Type II Trial in Singapore (16 weeks digital intervention)
Active, not recruiting
- Diabetes Mellitus, Type II
- 16 weeks digital intervention
-
Singapore, SingaporeEVYD Technology Limited
Dec 4, 2022
Obesity Complicating Childbirth, Fetal Anomaly Trial in Greenville (traxi® Panniculus Retractor)
Recruiting
- Obesity Complicating Childbirth
- Fetal Anomaly
- traxi® Panniculus Retractor
-
Greenville, South CarolinaPrisma Health
Mar 13, 2023
Psoriasis Trial in Nanjing (ICP-488, Placebo)
Recruiting
- Psoriasis
- ICP-488
- Placebo
-
Nanjing, Jiangsu, ChinaHospital for Skin Diseases, Institute of Dermatology, Chinese Ac
Aug 5, 2022
Diabetes, Type 2 Trial in Boston, Nashville (My Diabetes Care)
Not yet recruiting
- Diabetes Mellitus, Type 2
- My Diabetes Care
-
Boston, Massachusetts
- +1 more
Aug 4, 2022
Bleeding, Surgical Blood Loss, Seizures Trial in Canada, Russian Federation (Tranexamic Acid)
Recruiting
- Bleeding
- +2 more
- Tranexamic Acid
-
Kelowna, British Columbia, Canada
- +6 more
Aug 5, 2022
Thyroid Nodule (Benign) Trial (Device: Echopulse (HIFU ablation))
Not yet recruiting
- Thyroid Nodule (Benign)
- Device: Echopulse (HIFU ablation)
- (no location specified)
Oct 18, 2022
Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)
Completed
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg
- Placebo
-
Fort Smith, Arkansas
- +35 more
Aug 1, 2022
Hidradenitis Suppurativa Trial (NovaSorb® BTM, Human Cadaveric Allograft)
Not yet recruiting
- Hidradenitis Suppurativa
- NovaSorb® BTM
- Human Cadaveric Allograft
- (no location specified)
Jul 25, 2022
Sleep Disturbance Trial in San Francisco (Chorus Sleep)
Recruiting
- Sleep Disturbance
- Chorus Sleep
-
San Francisco, CaliforniaOnline
Jul 26, 2022
MDD Trial (NMRA-335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA-335140
- Placebo
- (no location specified)
Sep 21, 2023
MDD Trial (NMRA-335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA-335140
- Placebo
- (no location specified)
Sep 21, 2023
Opioid Use Disorder, Stimulant Use Disorder Trial in Minneapolis (Contingency Management)
Recruiting
- Opioid Use Disorder
- Stimulant Use Disorder
- Contingency Management
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 15, 2022
Alpha-1 Antitrypsin Deficiency (AATD), Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either
Recruiting
- Alpha-1 Antitrypsin Deficiency (AATD)
- +2 more
- Alvelestat (MPH966)
- Placebo
-
Birmingham, Alabama
- +8 more
Aug 31, 2021
Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in United States (biological,
Active, not recruiting
- Ovarian Granulosa Cell Tumor
- +6 more
- Bleomycin Sulfate
- +5 more
-
Anchorage, Alaska
- +218 more
Dec 30, 2021
IDD Trial in Asheville, Carrboro, Chapel Hill (GOACT, PEER)
Not yet recruiting
- IDD
- GOACT
- PEER
-
Asheville, North Carolina
- +2 more
Aug 3, 2023